US › Healthcare

Moolec Science SA Ordinary Shares (MLEC)

US · Healthcare · Biotechnology

$6.23+3.32%

Last close · 2026-09-17

Latest quarter · ended 2025-03-31

Revenue

$2.6M

Revenue YoY

+25.3%

Net profit

$-2.4M

EPS

$0.00

EPS estimate

$-0.06

Net margin

-91.8%

EPS came in at 0.00 against a street estimate of -0.06 — a beat of 100.0%.

Key statistics

Market cap

$4.4M

Forward P/E

0.0

P/B

0.52

Book value

$0.70

EPS (TTM)

$-181.12

52-week high

$23.22

52-week low

$3.08

50-day MA

$7.13

200-day MA

$7.51

Beta

-0.32

Analyst view

Analysts rate Moolec Science SA Ordinary Shares a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Shareholding

Insiders

21.06%

Institutions

0.07%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	2.28%
UBS Group AG	0.00%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Moolec Science SA Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.